 |
市場調査レポート
商品コード
1285963
バイオマテリアルの世界市場の規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2023年～2030年）Global Biomaterials Market Size, Share, Growth Analysis, By Type(Natural Biomaterial, Metallic Biomaterial), By Application(Neurology, Cardiology) - Industry Forecast 2023-2030 |
||||||
| バイオマテリアルの世界市場の規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2023年～2030年） |
|
出版日: 2023年04月29日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のバイオマテリアルの市場規模は、2022年の1,559億米ドルから2030年までに4,381億米ドルに達し、予測期間（2023年～2030年）にCAGRで15.4%の成長が予測されています。高齢化と慢性疾患の流行により、バイオマテリアルの需要が促進されています。
当レポートでは、世界のバイオマテリアル市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターのファイブフォース分析
- 将来の混乱についての特別な考察
世界のバイオマテリアル市場：タイプ別
- 市場の概要
- 天然バイオマテリアル
- 金属バイオマテリアル
- セラミックバイオマテリアル
- ポリマーバイオマテリアル
世界のバイオマテリアル市場：用途別
- 市場の概要
- 神経
- 心臓
- 整形外科
- 眼科
- 創傷ケア
- 歯科
- 形成外科
- その他の用途
世界のバイオマテリアルの市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主な成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Evonik Industries AG
- Corbion
- BASF SE
- Royal DSM NV
- Invibio Ltd.
- Carpenter Technology Corporation
- Celanese Corporation
- Berkeley Advanced Biomaterials, Inc.
- Cam Bioceramics B.V.
- Collagen Matrix, Inc.
- Bayer AG
- Medtronic plc
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- Danaher Corporation
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- 3M Company
- DuPont de Nemours, Inc.
Biomaterials Market size was valued at USD 135.4 billion in 2021 and is poised to grow from USD 155.9 billion in 2022 to USD 438.1 billion by 2030, growing at a CAGR of 15.4% in the forecast period (2023-2030).
The global biomaterials market refers to the industry that involves the production and application of materials that are compatible with biological systems, such as human tissues and organs. Biomaterials play a crucial role in medical and healthcare applications, including implantable medical devices, tissue engineering, drug delivery systems, and regenerative medicine. These materials are designed to interact with biological systems without causing adverse reactions and promote healing and tissue regeneration.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomaterials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
The Global biomaterials market is segmented on the basis of type, application, and region. Based on the type, the market is segmented into natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. Based on the application, the market is segmented as neurology, cardiology, orthopedics, ophthalmology, wound care, dental, plastic surgery, and other applications. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Driver
The aging population and the increasing prevalence of chronic diseases drive the demand for biomaterials. Biomaterials are used in various medical procedures, such as joint replacements, cardiovascular implants, and dental applications, to enhance the quality of life for patients suffering from age-related conditions or chronic illnesses. Technological advancements in medical devices and procedures fuel the demand for biomaterials. The development of innovative biomaterials enables the design of more effective and biocompatible medical implants, prosthetics, and drug delivery systems, leading to improved patient outcomes and expanded treatment options.
Restraint
The development and production of biomaterials involve extensive research, rigorous testing, and compliance with regulatory standards. These processes can be expensive, leading to higher costs associated with biomaterials. The high cost can limit their widespread adoption, particularly in resource-constrained healthcare systems.
Market Trends
There is a growing emphasis on bioactive and biodegradable biomaterials that can interact with the body's tissues, promote healing, and gradually degrade over time. These materials reduce the need for additional surgeries for implant removal, enhance patient comfort, and support the regeneration of functional tissues. The integration of 3D printing and additive manufacturing technologies in the production of biomaterials offers new opportunities for customization and precision in medical applications. 3D printing allows for the fabrication of complex structures, patient-specific implants, and scaffold designs, revolutionizing the field of personalized medicine and tissue engineering.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Biomaterials Market by Type
- Market Overview
- Natural Biomaterial
- Metallic Biomaterial
- Ceramic Biomaterial
- Polymeric Biomaterial
Global Biomaterials Market by Application
- Market Overview
- Neurology
- Cardiology
- Orthopedics
- Ophthalmology
- Wound Care
- Dental
- Plastic Surgery
- Other Applications
- Global Biomaterials Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Evonik Industries AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corbion
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BASF SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Royal DSM NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Invibio Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Carpenter Technology Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Celanese Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Berkeley Advanced Biomaterials, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cam Bioceramics B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Collagen Matrix, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wright Medical Group N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3M Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DuPont de Nemours, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
